EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer

Georgia Biniari iD, Christos Markatos iD, Agathi Nteli iD, Haralambos Tzoupis iD, Carmen Simal iD, Alexios Vlamis-Gardikas iD, Vlasios Karageorgos, Ioannis Pirmettis iD, Panagiota Petrou, Maria Venihaki iD, George Liapakis, Theodore Tselios iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242015232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Georgia Biniari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Patras, 26504 Rion, Greece. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was co-financed by the EUROPEAN UNION and the GREEK NATIONAL FUNDS through the Operational Program Competitiveness, Entrepreneurship and Innovati…, European Union and the Greek National Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gonadotropin-releasing hormone (GnRH) is pivotal in regulating human reproduction and fertility through its specific receptors. Among these, gonadotropin-releasing hormone receptor type I (GnRHR I), which is a member of the G-protein-coupled receptor family, is expressed on the surface of both healthy and malignant cells. Its presence in cancer cells has positioned this receptor as a primary target for the development of novel anti-cancer agents. Moreover, the extensive regulatory functions of GnRH have underscored decapeptide as a prominent vehicle for targeted drug delivery, which is accomplished through the design of appropriate conjugates. On this basis, a rationally designed series of anthraquinone/mitoxantrone–GnRH conjugates (con1–con8) has been synthesized herein. Their in vitro binding affinities range from 0.06 to 3.42 nM, with six of them (con2–con7) demonstrating higher affinities for GnRH than the established drug leuprolide (0.64 nM). Among the mitoxantrone based GnRH conjugates, con3 and con7 show the highest affinities at 0.07 and 0.06 nM, respectively, while the disulfide bond present in the conjugates is found to be readily reduced by the thioredoxin (Trx) system. These findings are promising for further pharmacological evaluation of the synthesized conjugates with the prospect of performing future clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansGonadotropin-Releasing HormoneImmunologic FactorsImmunosuppression TherapyImmunosuppressive AgentsMitoxantroneReceptors, LHRH

Stichwörter der Autor:innen

gonadotropin-releasing hormone (GnRH)hormone-dependent cancermitoxantronetargeted cancer therapythioredoxin system

Substanzen

Antineoplastic AgentsGonadotropin-Releasing HormoneImmunologic FactorsImmunosuppressive AgentsMitoxantroneReceptors, LHRH

Autor:innen und Institutionen

  • Department of Chemistry, University of Patras, 26504 Rion, Greece.
  • Department of Pharmacology, School of Medicine, University of Crete, 71003 Heraklion, Greece.
  • Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research "Demokritos", 15341 Athens, Greece.
  • Department of Clinical Chemistry, School of Medicine, University of Crete, 71003 Heraklion, Greece.

ORCID-Profile: Georgia Biniari, Christos Markatos, Agathi Nteli, Haralambos Tzoupis, Carmen Simal, Alexios Vlamis-Gardikas, Ioannis Pirmettis, Maria Venihaki, Theodore Tselios

Förderung

  • This research was co-financed by the EUROPEAN UNION and the GREEK NATIONAL FUNDS through the Operational Program Competitiveness, Entrepreneurship and Innovati…
  • European Union and the Greek National Funds

Zitieren

APA

Biniari, G., Markatos, C., Nteli, A., Tzoupis, H., Simal, C., Vlamis-Gardikas, A., Karageorgos, V., Pirmettis, I., Petrou, P., Venihaki, M., Liapakis, G., & Tselios, T. (2023). Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015232

Vancouver

Biniari G, Markatos C, Nteli A, Tzoupis H, Simal C, Vlamis-Gardikas A, et al. Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015232

BibTeX
@article{Biniari2023,
  author = {Biniari, Georgia and Markatos, Christos and Nteli, Agathi and Tzoupis, Haralambos and Simal, Carmen and Vlamis-Gardikas, Alexios and Karageorgos, Vlasios and Pirmettis, Ioannis and Petrou, Panagiota and Venihaki, Maria and Liapakis, George and Tselios, Theodore},
  title = {Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242015232}
}
Kostenlos starten →